Avalo Therapeutics, Inc. (AVTX) › Shares OutstandingAvalo Therapeutics, Inc. (AVTX) — Shares OutstandingAnnual figures by fiscal year, from SEC filings.2014: 649.7K2015: 8.65M2016: 9.43M2017: 31.27M2018: 40.80M2019: 44.38M2020: 75.00M2021: 9.40M2022: 39.3K2023: 801.7K2024: 10.47M2025: 18.51M18.51M2014Shares Outstanding (shares)2025Fiscal YearShares OutstandingChange YoY202518.51M+76.8%202410.47M+1206.1%2023801.7K+1940.4%202239.3K-99.6%20219.40M-87.5%202075.00M+69.0%201944.38M+8.8%201840.80M+30.5%201731.27M+231.4%20169.43M+9.1%20158.65M+1231.4%2014649.7K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresDividends Per Share